IKS Health IPO: A Promising Opportunity

IKS Health, a Jhunjhunwala-backed firm, is set to launch a ₹2,500 crore IPO on December 12, entirely through an offer-for-sale. With a price band of ₹1,265-1,329 per share, key shareholders, including Jhunjhunwala family trusts, expect high returns due to negligible acquisition costs. The IPO has attracted notable investors with substantial gains. Shares will list on December 19 on NSE and BSE. Analysts foresee robust demand for this healthcare services company, emphasizing its strong growth potential in the market.